K. A. Coşkun Et Al. , "HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression," Anti-Cancer Agents in Medicinal Chemistry , 2025
Coşkun, K. A. Et Al. 2025. HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression. Anti-Cancer Agents in Medicinal Chemistry .
Coşkun, K. A., Tutar, L., Abay, E. C., Gülüm, L., Çelik, A. B., GÜMÜŞ, M., ... KOCA, İ.(2025). HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression. Anti-Cancer Agents in Medicinal Chemistry .
Coşkun, Kübra Et Al. "HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression," Anti-Cancer Agents in Medicinal Chemistry , 2025
Coşkun, Kübra A. Et Al. "HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression." Anti-Cancer Agents in Medicinal Chemistry , 2025
Coşkun, K. A. Et Al. (2025) . "HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression." Anti-Cancer Agents in Medicinal Chemistry .
@article{article, author={Kübra Açıkalın Coşkun Et Al. }, title={HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression}, journal={Anti-Cancer Agents in Medicinal Chemistry}, year=2025}